Association of early dexamethasone therapy with mortality in critically Ill COVID-19 patients: a French multicenter study

BACKGROUND: Dexamethasone is recommended for COVID-19 patients who require oxygen therapy. However, its effectiveness in reducing mortality and intubation, and its safety, remain debated. We aimed to investigate whether dexamethasone reduces day-28 mortality in unselected patients with critical COVI...

Descripción completa

Detalles Bibliográficos
Autores principales: Raymond, Matthieu, Le Thuaut, Aurélie, Asfar, Pierre, Darreau, Cédric, Reizine, Florian, Colin, Gwenhaël, Dano, Charly, Lorber, Julien, Hourmant, Baptiste, Delbove, Agathe, Frérou, Aurélien, Morin, Jean, Egreteau, Pierre Yves, Seguin, Philippe, Reignier, Jean, Lascarrou, Jean-Baptiste, Canet, Emmanuel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9617242/
https://www.ncbi.nlm.nih.gov/pubmed/36308564
http://dx.doi.org/10.1186/s13613-022-01074-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9617242/
https://www.ncbi.nlm.nih.gov/pubmed/36308564
http://dx.doi.org/10.1186/s13613-022-01074-w

Ejemplares similares